obj groundhog day - tell me it isn't so!, page-19

"Some of us clearly expect GSK not only being interested in the FIM technology applications but see this as the tip of the iceberg and a pharmaceutical application to be followed.
This would explain the many years GSK has been involved with us."

Agree 110% Surges. It's very fair to say that GSK haven't been collaborating with obj for 5 years now when obj only invented and presented the FIM technology less than two years ago...

I've attempted scouring GSK's current clinical trials for any clues but they've got hundreds in their pipeline. It's worth checking out some recent additions to their more recently revamped website if you haven't looked at it in the last couple of weeks